– Interview with Marion MacFarlane, Ph.D., Group Leader, Receptor-mediated Signaling and Cell Death Program, Toxicology Unit, Medical Research Council, University of Leicester, U.K.

Previous articleAustralia Funds MS Research
Next articleNovartis to Further Orexo’s Mid-Stage GERD Treatment